Article discusses treatment for bipolar disorder

Article discusses treatment for bipolar disorder

To understand the medicines use patterns to treat patients with bipolar disorder type I. This is the aim of the most recent study of Evidências - Kantar Health published in an international journal. The article “Systematic literature review on patterns of pharmacological treatment and adherence among patients with bipolar disorder type I in the USA” was released by the Dovepress Journal, a prestigious journal in science and medicine. Luciano Paladini, Teresa Lemmer, and Otávio Clark, from the Evidências – Kantar Health team, conducted the study in partnership with a global client.

Bipolar disorder is a mental illness that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Bipolar disorder type I (BD-I) is a chronic condition characterized by periods of severe mood episodes from mania to depression. It is a life-long condition and, thus, requires long-term pharmacological treatment.

A systematic literature review was performed in MEDLINE and Embase databases searching for data on therapies and adherence to medications in type I bipolar disorder. The results showed that treatment prevalence for bipolar disorder type I in the USA, and that from 30% to 60% of patients with the disease do not receive appropriate treatment.

The article demonstrated that there is a need for studies specifically addressing patterns of therapy and adherence to pharmacological treatment in patients with type I bipolar disorder. This would help to better plan healthcare policies and improve adherence and persistence rates for bipolar disorder.

The study can be read at this link.


Subscribe to our newsletter